Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Janus kinase 2 inhibitors in myeloproliferative disorders.
Lucia E, Recchia AG, Gentile M, Bossio S, Vigna E, Mazzone C, Madeo A, Morabito L, Gigliotti V, De Stefano L, Caruso N, Servillo P, Franzese S, Bisconte MG, Gentile C, Morabito F. Lucia E, et al. Among authors: morabito l, morabito f. Expert Opin Investig Drugs. 2011 Jan;20(1):41-59. doi: 10.1517/13543784.2011.538382. Epub 2010 Dec 4. Expert Opin Investig Drugs. 2011. PMID: 21128825 Review.
Lenalidomide in the treatment of chronic lymphocytic leukemia.
Gentile M, Recchia AG, Vigna E, Mazzone C, Lucia E, Gigliotti V, Bossio S, Madeo A, Morabito L, Servillo P, Franzese S, Caruso N, De Stefano L, Bisconte MG, Gentile C, Morabito F. Gentile M, et al. Among authors: morabito l, morabito f. Expert Opin Investig Drugs. 2011 Feb;20(2):273-86. doi: 10.1517/13543784.2011.546343. Epub 2011 Jan 10. Expert Opin Investig Drugs. 2011. PMID: 21214505 Review.
Epigenetic regulation in myelodysplastic syndromes: implications for therapy.
Vigna E, Recchia AG, Madeo A, Gentile M, Bossio S, Mazzone C, Lucia E, Morabito L, Gigliotti V, Stefano LD, Caruso N, Servillo P, Franzese S, Fimognari F, Bisconte MG, Gentile C, Morabito F. Vigna E, et al. Among authors: morabito l, morabito f. Expert Opin Investig Drugs. 2011 Apr;20(4):465-93. doi: 10.1517/13543784.2011.559164. Epub 2011 Mar 8. Expert Opin Investig Drugs. 2011. PMID: 21381982 Review.
Promising therapies for the treatment of chronic lymphocytic leukemia.
Morabito F, Recchia AG, Vigna E, De Stefano L, Bossio S, Morabito L, Pellicanò M, Palummo A, Storino F, Caruso N, Gentile M. Morabito F, et al. Among authors: morabito l. Expert Opin Investig Drugs. 2015 Jun;24(6):795-807. doi: 10.1517/13543784.2015.1021920. Epub 2015 Mar 1. Expert Opin Investig Drugs. 2015. PMID: 25728009 Review.
Ixazomib for the treatment of multiple myeloma.
Gentile M, Offidani M, Vigna E, Corvatta L, Recchia AG, Morabito L, Morabito F, Gentili S. Gentile M, et al. Among authors: morabito l, morabito f. Expert Opin Investig Drugs. 2015;24(9):1287-98. doi: 10.1517/13543784.2015.1065250. Epub 2015 Jul 3. Expert Opin Investig Drugs. 2015. PMID: 26138345 Review.
Sorafenib for the treatment of multiple myeloma.
Gentile M, Martino M, Recchia AG, Vigna E, Morabito L, Morabito F. Gentile M, et al. Among authors: morabito l, morabito f. Expert Opin Investig Drugs. 2016 Jun;25(6):743-9. doi: 10.1517/13543784.2016.1169272. Epub 2016 Apr 6. Expert Opin Investig Drugs. 2016. PMID: 26998658 Review.
An old drug with a new future: bendamustine in multiple myeloma.
Gentile M, Recchia AG, Mazzone C, Vigna E, Martino M, Morabito L, Lucia E, Bossio S, De Stefano L, Granata T, Palummo A, Morabito F. Gentile M, et al. Among authors: morabito l, morabito f. Expert Opin Pharmacother. 2013 Nov;14(16):2263-80. doi: 10.1517/14656566.2013.837885. Epub 2013 Sep 21. Expert Opin Pharmacother. 2013. PMID: 24053161 Review.
Smoldering multiple myeloma: to treat or not to treat.
Gentile M, Offidani M, Vigna E, Corvatta L, Recchia AG, Morabito L, Martino M, Morabito F, Gentili S. Gentile M, et al. Among authors: morabito l, morabito f. Expert Opin Pharmacother. 2015 Apr;16(6):785-90. doi: 10.1517/14656566.2015.1007952. Epub 2015 Feb 8. Expert Opin Pharmacother. 2015. PMID: 25659943 Review.
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H, Galimberti S, Salah Z, Morabito L, Mujahed A, Hindiyeh M, Dono M, Fais F, Cutrona G, Neri A, Tripepi G, Fronza G, Ferrarini M. Morabito F, et al. Among authors: morabito l. Expert Opin Investig Drugs. 2020 Aug;29(8):869-880. doi: 10.1080/13543784.2020.1783239. Epub 2020 Jun 27. Expert Opin Investig Drugs. 2020. PMID: 32551999 Free article. Review.
78 results